Key information
On 29 October, PolyU described research using a Tumour Heterogeneity Index derived from contrast-enhanced MRI to assess response to a particular breast cancer treatment.
On 29 October, PolyU described research using a Tumour Heterogeneity Index derived from contrast-enhanced MRI to assess response to a particular breast cancer treatment.